Remove Cardiology Remove Life Science Remove Medicine Remove Nurses
article thumbnail

Introducing the new NIHR National Patient Recruitment Centres

pharmaphorum

One of the Sector Deal 2 commitments within the Government’s Life Sciences Industrial Strategy, the NPRCs are the first NIHR-funded research infrastructure that is 100% dedicated to delivering commercial research.

article thumbnail

Introducing the new NHS Patient Recruitment Centres

pharmaphorum

One of the Sector Deal 2 commitments within the Government’s Life Sciences Industrial Strategy, the NPRCs are the first NIHR-funded research infrastructure that is 100% dedicated to delivering commercial research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Drug Discovery World

Access to medicines and healthcare has since been challenging in both countries. It was a subject of intense ethical debate whether life sciences companies should join other industries in leveraging sanctions against Russia, though many issued statements to say they had ceased clinical trial activity in the country.

article thumbnail

Cardiac Biomarkers in Cardiovascular Clinical Trials: Caveats and Considerations

XTalks

This is a part of the precision cardiology approach and could lead to their use as prognostic indicators. James Januzzi, MD, staff cardiologist at Massachusetts General Hospital and Hutter Family professor of medicine at Harvard Medical School, specializes in biomarker testing in heart disease and treatment of heart failure.